Designing Clinical Trials
Overview
The most commonly performed clinical trials evaluate drug candidates, medical devices, biologics and other interventions in patients in strictly controlled scientific settings and are required for regulatory approval for commercial use of the therapies. Trials may be designed to assess the safety and efficacy of an experimental therapy to determine whether the new intervention is better than the standard therapy or to compare the efficacy to other marketed interventions. Trial objectives and design are typically documented in the clinical trial protocol. This course is organized to explore the process of clinical trial design in a sequential manner and provide an overview of the different types of trial designs commonly used today. Participants will ultimately design a sample protocol and informed consent procedure.
Who will benefit
This course will be beneficial to those who are new to clinical research or those with experience in clinical research but with limited exposure to study protocol and trial design. Clinical research associates, compliance and quality team members, study coordinators and investigators will also benefit.
Key topics
- Experimental design
- Alternative trial design
- Investigational New Drug (IND) applications and management; fast-track applications and trials, Phase 4 studies and quality of life trials
- Regulatory standards: Good Clinical Practice (GCP) and Institutional Review Boards (IRBs)
- Subject recruitment and retention
- Research ethics and informed consent
- Data and safety monitoring for clinical trials
Learning outcomes
- Understanding of the fundamentals of clinical trials and of the differentiation of clinical trials from other types of clinical and epidemiologic investigations
- Identification of the basic ethical principles that guide the design of clinical trials
- Specification of variables requiring special attention for quality control and the implementation of monitoring procedures
- Identification and comparison of various approaches to interim analyses for safety and efficacy studies
- Examination of published results of a clinical trial
Click here to learn more about bringing this course in-house.